View in EDS

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera.

Saved in:
Bibliographic Details
Title: Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera.
Authors: Roques P; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Fritzer A; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Dereuddre-Bosquet N; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Wressnigg N; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Hochreiter R; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Bossevot L; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Pascal Q; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Guehenneux F; Valneva SE, Saint Herblain, France., Bitzer A; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Corbic Ramljak I; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Le Grand R; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Lundberg U; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Meinke A; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.
Source: JCI insight [JCI Insight] 2022 Jul 22; Vol. 7 (14). Date of Electronic Publication: 2022 Jul 22.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35700051
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Roques+P%22">Roques P</searchLink>; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Fritzer+A%22">Fritzer A</searchLink>; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Dereuddre-Bosquet+N%22">Dereuddre-Bosquet N</searchLink>; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Wressnigg+N%22">Wressnigg N</searchLink>; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Hochreiter+R%22">Hochreiter R</searchLink>; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Bossevot+L%22">Bossevot L</searchLink>; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Pascal+Q%22">Pascal Q</searchLink>; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Guehenneux+F%22">Guehenneux F</searchLink>; Valneva SE, Saint Herblain, France.<br /><searchLink fieldCode="AU" term="%22Bitzer+A%22">Bitzer A</searchLink>; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Corbic+Ramljak+I%22">Corbic Ramljak I</searchLink>; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Le+Grand+R%22">Le Grand R</searchLink>; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.<br /><searchLink fieldCode="AU" term="%22Lundberg+U%22">Lundberg U</searchLink>; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Meinke+A%22">Meinke A</searchLink>; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676073%22">JCI insight</searchLink> [JCI Insight] 2022 Jul 22; Vol. 7 (14). <i>Date of Electronic Publication: </i>2022 Jul 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676073 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2379-3708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223793708%22">23793708 </searchLink><i>NLM ISO Abbreviation: </i>JCI Insight <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35700051
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/jci.insight.160173
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Roques P
      – PersonEntity:
          Name:
            NameFull: Fritzer A
      – PersonEntity:
          Name:
            NameFull: Dereuddre-Bosquet N
      – PersonEntity:
          Name:
            NameFull: Wressnigg N
      – PersonEntity:
          Name:
            NameFull: Hochreiter R
      – PersonEntity:
          Name:
            NameFull: Bossevot L
      – PersonEntity:
          Name:
            NameFull: Pascal Q
      – PersonEntity:
          Name:
            NameFull: Guehenneux F
      – PersonEntity:
          Name:
            NameFull: Bitzer A
      – PersonEntity:
          Name:
            NameFull: Corbic Ramljak I
      – PersonEntity:
          Name:
            NameFull: Le Grand R
      – PersonEntity:
          Name:
            NameFull: Lundberg U
      – PersonEntity:
          Name:
            NameFull: Meinke A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 07
              Text: 2022 Jul 22
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2379-3708
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: JCI insight
              Type: main
ResultId 1